Information about Piret Pharma
My details
*
*
*

Piret Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0783.830.868

VAT liability
Yes
Established
25-03-2022
Last balance sheet year
2025
Company size
Small 1,1 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Piret Pharma

2025 2024 2023
Income statement
Profit/Loss € 35,490 -27% € 48,323 28% € 37,860
Gross margin € 171,047 -6% € 181,751 -26% € 245,891
Balance sheet
Balance sheet total € 675,213 -5% € 710,417 -9% € 779,293
Equity € 126,674 39% € 91,183 113% € 42,860
Debts € 548,539 -11% € 619,234 -16% € 736,432
Other
Employees 1.1 1.1 1.1

Publications from Piret Pharma

Date Publication
29-03-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Piret Pharma?
The VAT number of Piret Pharma is BE 0783.830.868.
Wat is the PEPPOL ID of Piret Pharma?
The PEPPOL ID of Piret Pharma is 0208:0783830868. Log in or start a free trial to see the full overview.
When was Piret Pharma founded?
Piret Pharma was founded on 25-03-2022.
What is the address of Piret Pharma?
The current registered office of Piret Pharma is located at Rue de Beaumont 147, 6030 Charleroi.
When was the last time Piret Pharma filed their annual financial statements?
The most recent financial statements of Piret Pharma were filed on 27-08-2026.
How many employees does Piret Pharma have?
There are 1,1 FTEs working at Piret Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Piret Pharma?
At the time of its most recent financial statements, Piret Pharma did not publish any turnover figures. Piret Pharma reported a gross margin of €171,047.02.